US2020241003A1PendingUtilityA1
T-cell epitope identification
Assignee: BRITISH COLUMBIA CANCER AGENCYPriority: Mar 27, 2014Filed: Apr 7, 2020Published: Jul 30, 2020
Est. expiryMar 27, 2034(~7.7 yrs left)· nominal 20-yr term from priority
C12N 15/1037G01N 33/6878C12Q 1/6886C12N 15/1086G01N 33/5091G01N 33/56972G01N 33/6845C12Q 2600/158
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is a method for determining the identity of the epitopes recognized by T-cells. The method consists of expressing an encoded library of candidate epitope sequences in a recipient reporter cell capable of providing a detectable signal upon cytotoxic attack from a single cognate T-cell followed by contacting the reporter cells with T-cells of interest. The reporter cells with a signal indicating cytotoxic attack from a T-cell are isolated and then analyzed by next-generation sequencing in order to identify the epitope sequences.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method for determining epitopes recognized by cytotoxic lymphocytes, the method comprising the steps of:
expressing a library of candidate epitope-encoding nucleic acids in reporter cells capable of presenting expressed peptides of such candidate epitope-encoding nucleic acids in the context of a membrane-bound major histocompatibility complex (MHC) protein wherein the reporter cells are modified to carry an optically-based signaling system that generates an optical signal whenever a peptide linkage in the system is enzymatically cleaved by a serine protease from granules of a cytotoxic lymphocyte upon recognition of an expressed peptide in the context of an MHC protein on a reporter cell by such cytotoxic lymphocyte; contacting in a reaction mixture a mixed population of reporter cells expressing different candidate epitope-encoding nucleic acids of the library with a sample comprising cytotoxic lymphocytes, wherein effector functions of cytotoxic lymphocytes recognizing reporter cells are activated so that serine proteases in granules of the cytotoxic lymphocytes are delivered by a granzyme-perforin pathway to recognized reporter cells and cause an optical signal to be generated by the reporter cells; isolating intact reporter cells generating optical signals; extracting candidate epitope-encoding nucleic acids from the isolated intact reporter cells; and sequencing the candidate epitope-encoding nucleic acids of the reporter cells to identify the epitope-encoding nucleic acids.
22 . The method of claim 21 wherein said sample is from an individual and said MHC proteins of said reporter cells are matched with MHC proteins expressed by the individual.
23 . The method of claim 22 wherein said reporter cells comprise autologous cells of said individual genetically modified to express candidate epitopes of said library.
24 . The method of claim 23 wherein said autologous cells are B cells of said individual.
25 . The method of claim 24 wherein said autologous cells are stably transfected or transformed by a vector capable of expressing said candidate epitopes of said library.
26 . The method of claim 23 wherein said reporter cells are genetically modified to express a FRET-based fluorescent protein signaling system that generates a fluorescent signal whenever enzymatically cleaved by one of said serine proteases.
27 . The method of claim 21 wherein said serine protease is a granzyme.
28 . The method of claim 27 wherein said granzyme is a granzyme A, B, H, K or M.
29 . The method of claim 21 wherein said cytotoxic lymphocytes are cytotoxic T cells or natural killer cells.
30 . A method for determining epitopes recognized by cytotoxic lymphocytes, the method comprising the steps of:
(a) expressing a library of candidate epitope-encoding nucleic acids or an enriched library of candidate epitope-encoding nucleic acids in reporter cells capable of presenting expressed peptides of such candidate epitope-encoding nucleic acids in the context of a membrane-bound major histocompatibility complex (MHC) protein wherein the reporter cells are modified to carry an optically-based signaling system that generates an optical signal whenever a peptide linkage in the system is enzymatically cleaved by a serine protease from granules of a granzyme-perforin pathway of a cytotoxic lymphocyte upon recognition of an expressed peptide in the context of an MHC protein on a reporter cell by such cytotoxic lymphocyte; (b) contacting in a reaction mixture a mixed population of reporter cells expressing different candidate epitope-encoding nucleic acids of the library with a sample comprising cytotoxic lymphocytes; (c) isolating reporter cells generating an optical signal indicating recognition by a cytotoxic lymphocyte; (d) extracting candidate epitope-encoding nucleic acids from the isolated reporter cells and generating therefrom an enriched library of candidate epitope-encoding nucleic acids; (e) repeating steps (a)-(d) with the enriched library of candidate epitope-encoding nucleic acids until a frequency of reporter cells generating the signal indicating recognition by a cytotoxic lymphocyte is greater than or equal to a predetermined value; (f) sequencing the candidate epitope-encoding nucleic acids of reporter cells generating said signal to identify sequences of the epitope-encoding nucleic acids.
31 . The method of claim 30 wherein said optical signal indicating recognition by a cytotoxic lymphocyte is a fluorescent signal and said step of isolating includes sorting said reporter cells by a fluorescently activated cell sorter (FACS).
32 . The method of claim 30 wherein said serine protease is a granzyme.
33 . The method of claim 32 wherein said granzyme is a granzyme A, B, H, K or M.
34 . The method of claim 32 wherein said cytotoxic lymphocytes are cytotoxic T cells or natural killer cells.
35 . A method for testing the presence and level of cellular immunity in an individual to a predetermined antigen or class of antigens comprising the steps of:
(a) providing reporter cells expressing a library of epitopes derived from the predetermined antigen or class of antigens, the reporter cells being MHC matched to the individual, and the reporter cells each having an optically-based signaling system that generates an optical signal whenever a peptide linkage in the system is enzymatically cleaved by a serine protease from granules of a granzyme-perforin pathway of a cytotoxic lymphocyte activated upon recognition of an expressed peptide in the context of an MHC protein on the reporter cell by such cytotoxic lymphocyte; (b) combining the reporter cells with a sample of cytotoxic lymphocytes from the individual; (c) determining a level of cellular immunity of the individual to the predetermined antigen or class of antigens by a number or frequency of reporter cells generating an optical signal.
36 . The method of claim 35 wherein said optical signal of said reporter cell is generated by a FRET-based fluorescent protein signaling system.
37 . The method of claim 35 wherein said predetermined antigen or class of antigens are proteins from an infectious agent.
38 . The method of claim 37 wherein said infectious agent is a virus, a bacteria, a fungus, or a protozoa.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.